Marshall Wace, LLP Rezolute, Inc. Put Options Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$40.8 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$8.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$7.65 Million1.66% of portfolio
-
Blackstone Inc New York, NY1.74MShares$6.32 Million0.02% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.7MShares$6.15 Million0.55% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $141M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...